Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemia-Reference-Cited by-同舟云学术

Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemia

Published:2014-06-15 Issue:12 Volume:71 Page:1001-1008
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Davis Kyle A.¹,Miyares Marta A.¹

Affiliation:

1. Jackson Memorial Hospital, Miami, FL

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/71/12/1001/28372742/ajhp1001.pdf

Reference28 articles.

1. Emerging low-density lipoprotein therapies: microsomal triglyceride transfer protein inhibitors;Goldberg;J Clin Lipidol,2013

2. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia;Robinson;J Manag Care Pharm,2013

3. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment;Raal;Atherosclerosis,2012

4. Recent advances in the treatment of homozygous familial hypercholesterolaemia;Marais;Curr Opin Lipidol,2013

5. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association expert panel on familial hypercholesterolemia;Goldberg;J Clin Lipidol,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress in the Clinical Treatment of Familial Hypercholesterolemia;Current Medicinal Chemistry;2024-03

2. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022;Journal of Atherosclerosis and Thrombosis;2023

3. Dyslipidemia in the Pediatric Population;Endocrine Conditions in Pediatrics;2020-09-26

4. Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide;Current Medicinal Chemistry;2020-07-01

5. Novel emerging therapies in atherosclerosis targeting lipid metabolism;Expert Opinion on Investigational Drugs;2020-05-22